E R Nascimento1, A C O Maia2, A E Nardi3, A C Silva4. 1. Laboratory of Panic and Respiration - Institute of Psychiatry, Universidade Federal do Rio de Janeiro, Brazil. Electronic address: bete_nascimentopsi@ig.com.br. 2. Laboratory of Panic and Respiration - Institute of Psychiatry, Universidade Federal do Rio de Janeiro, Brazil. Electronic address: acornelas@mvmaia.com.br. 3. Laboratory of Panic and Respiration - Institute of Psychiatry, Universidade Federal do Rio de Janeiro, Brazil; National Institute for Science and Technology - Translational Medicine, Brazil. Electronic address: antonioenardi@gmail.com. 4. Laboratory of Panic and Respiration - Institute of Psychiatry, Universidade Federal do Rio de Janeiro, Brazil; National Institute for Science and Technology - Translational Medicine, Brazil. Electronic address: adrianacardosorj@yahoo.com.br.
Abstract
INTRODUCTION: Although high blood pressure is known to be associated with sexual dysfunction, this phenomenon has been little studied in females and has received little intervention in clinical practice. OBJECTIVE: To identify the presence of sexual dysfunction, considering the different possible domains and to evaluate its relationship with the presence of symptoms of anxiety and depression in women with arterial hypertension. METHODOLOGY: One hundred fifty seven women (from 56.4 years) with a diagnosis of arterial hypertension were evaluated with media through the Female Sexual Function Index (FSFI) and the Hospital Anxiety and Depression Scale (HADS). RESULTS: High rates of sexual dysfunction were detected in the women evaluated, and this dysfunction was in all domains as follows: desire (68.2%), excitement (68.2%), lubrication (41.1%), orgasm (55.4%), satisfaction (66.42%) and pain (56.1%). Elevated rates of symptoms of anxiety (43.3%) and depression (26.8%) were also found in our sample. Nevertheless, in the present study, such symptoms showed no relationship with sexual dysfunction levels for any of the domains assessed. CONCLUSION: Hypertensive patients exhibit an elevated presence of sexual dysfunction, as well as anxious and depressive symptoms. Although the literature on female sexuality indicates influences of these symptoms on sexual functions, this study did not identify such a relationship in the studied population. Sexuality is an important element in patient quality of life, and a broad understanding of female sexual function is fundamental for good follow-up in these patients.
INTRODUCTION: Although high blood pressure is known to be associated with sexual dysfunction, this phenomenon has been little studied in females and has received little intervention in clinical practice. OBJECTIVE: To identify the presence of sexual dysfunction, considering the different possible domains and to evaluate its relationship with the presence of symptoms of anxiety and depression in women with arterial hypertension. METHODOLOGY: One hundred fifty seven women (from 56.4 years) with a diagnosis of arterial hypertension were evaluated with media through the Female Sexual Function Index (FSFI) and the Hospital Anxiety and Depression Scale (HADS). RESULTS: High rates of sexual dysfunction were detected in the women evaluated, and this dysfunction was in all domains as follows: desire (68.2%), excitement (68.2%), lubrication (41.1%), orgasm (55.4%), satisfaction (66.42%) and pain (56.1%). Elevated rates of symptoms of anxiety (43.3%) and depression (26.8%) were also found in our sample. Nevertheless, in the present study, such symptoms showed no relationship with sexual dysfunction levels for any of the domains assessed. CONCLUSION:Hypertensivepatients exhibit an elevated presence of sexual dysfunction, as well as anxious and depressive symptoms. Although the literature on female sexuality indicates influences of these symptoms on sexual functions, this study did not identify such a relationship in the studied population. Sexuality is an important element in patient quality of life, and a broad understanding of female sexual function is fundamental for good follow-up in these patients.
Authors: Van T Hoang; Hoang-Phuong Nguyen; Viet Nhan Nguyen; Duc M Hoang; Tan-Sinh Thi Nguyen; Liem Nguyen Thanh Journal: Front Cell Dev Biol Date: 2022-09-28
Authors: Mehmet Ali Karagöz; Abdullah Gül; Charmaine Borg; İsmet Bilger Erihan; Mehmet Uslu; Mehmet Ezer; Ahmet Erbağcı; Binali Çatak; Murat Bağcıoğlu Journal: Int J Impot Res Date: 2020-12-16 Impact factor: 2.408